• 1
    Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group. World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl.):147334.
  • 2
    Weir E. The burden of rhinitis: nothing to sniff at JMAC. CMAJ 2003;169:694.
  • 3
    Devenny A, Wassall H, Ninan T, Omran M, Daud Khan S, Russell G. Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years. BMJ 2004;329:489490.
  • 4
    Anderson H, Ruggles R, Strachan D et al. Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12-14 year olds in the British Isles, 1995–2002: questionnaire survey. BMJ 2004;328:10521053.
  • 5
    ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:12251232.
  • 6
    Storms W. Rethinking our approach to allergic rhinitis management. Ann Allergy Asthma Immunol 2002;4(Suppl.1):3035.
  • 7
    Crane J, Mallol J, Beasley R, Stewart A, Asher M. On behalf of the International Study of Asthma and Allergies in Childhood (ISAAC) Phase I study group Agreement between written and video questions for comparing asthma symptoms in ISAAC. Eur Respir J 2003;21:455461.
  • 8
    Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005;60:350353.
  • 9
    Demoly P, Allaert A, Lecasble M et al. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003;58:672675.
  • 10
    Leynaert B, Bousquet J, Neukirch C et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301304.
  • 11
    Plácido M, Gaspar A, Morais-Almeida M, Romeira A, Almeida-Vau T, Neto-Braga C et al. Rhinitis as a risk factor for persistence of symptoms in childhood recurrent wheezing: an 8- year prospective study. In: MaroneG, editor. Clinical Immunology and Allergy in Medicine. Naples: JGC Editions, 2003: 437441.
  • 12
    Crystal-Peters J, Crown W, Goetzel R, Schutt D. The cost of productivity losses associated with allergic rhinitis. Am J Manage Care 2000;6:373378.
  • 13
    Castel Branco MG, Rodrigues J, Ferraz de Oliveira J et al. A cross-sectional epidemiological study of the prevalence of rhinitis in Portugal in the year 1998. Allergy 2000;55(Suppl.63):39.
  • 14
    Loureiro AC, Todo Bom A, Pereira C et al. Prescriptions given by general practitioners to patients with rhinitis. Allergy 2000;55:43.
  • 15
    Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687695.
  • 16
    Loureiro AC, Chieira C, Pereira AC et al. Estudos epidemiológicos da Asma Brônquica numa população adulta. Rev Port Imunoalergol 1996;4:3554.
  • 17
    Nunes C, Ladeira S, Rosado Pinto JE. Definição, Epidemiologia e classificação da asma na criança in A Criança Asmática no Mundo da Alergia. Rosado PintoJEMorais de AlmeidaM, editors. Euromédice 2003;3555.
  • 18
    Robertson C, Roberts M, Kappers J. Asthma prevalence in Melbourne schoolchildren: have we reached the peak? Med J Aust 2004;180:273276.
  • 19
    Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis [Evidence Report/Technology Assessment no 54]. Washington: The Agency, 2002.
  • 20
    Fernández-Mayoralas M, Caballero J, Álvarez L. Asociación entre dermatitis atópica, rinitis alérgica y asma en escolares de 13 y 14 años. Anals de Pediatria 2004;60:236242.
  • 21
    Vignola AM, Scichilone N, Bousquet J, Bonsignore G, Bellia V. Aging and asthma: pathophysiological mechanisms. Allergy 2003;58:165175.
  • 22
    Huss K, Naumann PL, Mason PJ et al. Asthma severety, atopic status, allergen exposure, and quality of life in elderly persons. Ann Allergy Asthma Immunol 2001;86:524530.
  • 23
    D’Amato G, Spieksma F, Liccardi G et al. EAACI position paper: pollen-related allergy in Europe. Allergy 1998;53:567578.
  • 24
    D’Amato G, Liccardi G. Pollen-related allergy in the European Mediterranean area. Clin Exp Allergy 1994;24:210219.
  • 25
    Von Mutius E. The environmental predictors of allergic disease. J Allergy Clin Immunol 2000;105:919.
  • 26
  • 27
    Devalia J, Rusznak C, Davies R. Allergen/irritant interaction – its role in sensitisation and allergic disease. Allergy 1998;53:335345.
  • 28
    Loureiro G, Rabaça MA, Blanco B, Andrade S, Chieira C, Pereira C. Urban versus rural environment- any differences in aeroallergens sensitization in allergic population of Cova da Beira, Portugal? Allerg Imunol (Paris) 2005;37:187193.
  • 29
    D’Amato G, Liccardi G, D’Amato M, Cazzola M. The role of outdoor air pollution and climatic changes on the rising trends in respiratory allergy. Respire Med 2001;95:606611.